193 related articles for article (PubMed ID: 20486981)
1. Effect of an endurance-like exercise on the disposition and detection time of phenylbutazone and dexamethasone in the horse: application to medication control.
Authie EC; Garcia P; Popot MA; Toutain PL; Doucet M
Equine Vet J; 2010 Apr; 42(3):240-7. PubMed ID: 20486981
[TBL] [Abstract][Full Text] [Related]
2. How to extrapolate a withdrawal time from an EHSLC published detection time: a Monte Carlo simulation appraisal.
Toutain PL
Equine Vet J; 2010 Apr; 42(3):248-54. PubMed ID: 20486982
[TBL] [Abstract][Full Text] [Related]
3. Veterinary medicines and competition animals: the question of medication versus doping control.
Toutain PL
Handb Exp Pharmacol; 2010; (199):315-39. PubMed ID: 20204593
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of phenylbutazone in neonatal foals.
Wilcke JR; Crisman MV; Sams RA; Gerken DF
Am J Vet Res; 1993 Dec; 54(12):2064-7. PubMed ID: 8116939
[TBL] [Abstract][Full Text] [Related]
5. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
Mills PC; Ng JC; Auer DE
J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of dexamethasone with pharmacokinetic/pharmacodynamic model of the effect of dexamethasone on endogenous hydrocortisone and cortisone in the horse.
Soma LR; Uboh CE; Luo Y; Guan F; Moate PJ; Boston RC
J Vet Pharmacol Ther; 2005 Feb; 28(1):71-80. PubMed ID: 15720518
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses.
Foreman JH; Grubb TL; Inoue OJ; Banner SE; Ball KT
Equine Vet J Suppl; 2010 Nov; (38):601-5. PubMed ID: 21059067
[TBL] [Abstract][Full Text] [Related]
9. [The concentration changes of different phenylbutazone formulations in horse plasma].
Keller H; Hashem A
Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of triamcinolone acetonide following intramuscular and intra-articular administration to exercised Thoroughbred horses.
Knych HK; Vidal MA; Casbeer HC; McKemie DS
Equine Vet J; 2013 Nov; 45(6):715-20. PubMed ID: 23574452
[TBL] [Abstract][Full Text] [Related]
11. Single-injection glucose kinetics with compartmental modelling during rest and low-intensity exercise in horses.
Treiber KH; Boston RC; Geor RJ; Hess TM; Harris PA; Kronfeld DS
Equine Vet J Suppl; 2010 Nov; (38):361-9. PubMed ID: 21059031
[TBL] [Abstract][Full Text] [Related]
12. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of dexamethasone after oral administration in apparently healthy horses.
Grady JA; Davis EG; Kukanich B; Sherck AB
Am J Vet Res; 2010 Jul; 71(7):831-9. PubMed ID: 20594087
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and anti-inflammatory effects of flunixin meglumine as a sole agent and in combination with phenylbutazone in exercised Thoroughbred horses.
Knych HK; Arthur RM; McKemie DS; Baden RW; Seminoff K; Kass PH
Equine Vet J; 2021 Jan; 53(1):102-116. PubMed ID: 32145701
[TBL] [Abstract][Full Text] [Related]
15. The bioavailability of phenylbutazone in the horse.
Smith PB; Caldwell J; Smith RL; Horner MW; Moss MS
Xenobiotica; 1987 Apr; 17(4):435-43. PubMed ID: 3604253
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves.
Arifah AK; Lees P
J Vet Pharmacol Ther; 2002 Aug; 25(4):299-309. PubMed ID: 12213119
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary vascular pressures of strenuously exercising thoroughbreds after administration of phenylbutazone.
Manohar M; Goetz TE; Griffin R; Sullivan E
Am J Vet Res; 1996 Sep; 57(9):1354-8. PubMed ID: 8874732
[TBL] [Abstract][Full Text] [Related]
18. The use of phenylbutazone in the horse.
Soma LR; Uboh CE; Maylin GM
J Vet Pharmacol Ther; 2012 Feb; 35(1):1-12. PubMed ID: 21668837
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of phenylbutazone given intravenously or orally in mature Holstein bulls.
Williams RJ; Smith JA; Boudinot FD; Knight AP
Am J Vet Res; 1990 Mar; 51(3):367-70. PubMed ID: 2316911
[TBL] [Abstract][Full Text] [Related]
20. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
Foreman JH; Ruemmler R
Equine Vet J Suppl; 2011 Nov; (40):12-7. PubMed ID: 22082440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
